New York 2023-2024 Regular Session

New York Senate Bill S07753

Introduced
11/15/23  
Refer
11/15/23  

Caption

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Companion Bills

NY A08130

Same As Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Previously Filed As

NY A08130

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

NY S02383

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

NY SB1502

Controlled substances: xylazine.

NY SB6

Controlled substances: xylazine.

NY HB106

Adds Xylazine to Schedule II of the Uniform Controlled Dangerous Substances Law

NY A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

NY HB2749

Adds xylazine to the list of Schedule III controlled substances

NY S191

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY A1526

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY HB1661

Further providing for schedules of controlled substances; and providing for secure storage of xylazine.

Similar Bills

No similar bills found.